TY - JOUR
T1 - POU3F3-related disorder
T2 - Defining the phenotype and expanding the molecular spectrum
AU - Rossi, Alessandra
AU - Blok, Lot Snijders
AU - Neuser, Sonja
AU - Klöckner, Chiara
AU - Platzer, Konrad
AU - Faivre, Laurence Olivier
AU - Weigand, Heike
AU - Dentici, Maria L
AU - Tartaglia, Marco
AU - Niceta, Marcello
AU - Alfieri, Paolo
AU - Srivastava, Siddharth
AU - Coulter, David
AU - Smith, Lacey
AU - Vinorum, Kristin
AU - Cappuccio, Gerarda
AU - Brunetti-Pierri, Nicola
AU - Torun, Deniz
AU - Arslan, Mutluay
AU - Lauridsen, Mathilde F
AU - Murch, Oliver
AU - Irving, Rachel
AU - Lynch, Sally A
AU - Mehta, Sarju G
AU - Carmichael, Jenny
AU - Zonneveld-Huijssoon, Evelien
AU - de Vries, Bert
AU - Kleefstra, Tjitske
AU - Johannesen, Katrine M
AU - Westphall, Ian T
AU - Hughes, Susan S
AU - Smithson, Sarah
AU - Evans, Julie
AU - Dudding-Byth, Tracy
AU - Simon, Marleen
AU - van Binsbergen, Ellen
AU - Herkert, Johanna C
AU - Beunders, Gea
AU - Oppermann, Henry
AU - Bakal, Mert
AU - Møller, Rikke S
AU - Rubboli, Guido
AU - Bayat, Allan
N1 - © 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
PY - 2023/8
Y1 - 2023/8
N2 - POU3F3 variants cause developmental delay, behavioral problems, hypotonia and dysmorphic features. We investigated the phenotypic and genetic landscape, and genotype-phenotype correlations in individuals with POU3F3-related disorders. We recruited unpublished individuals with POU3F3 variants through international collaborations and obtained updated clinical data on previously published individuals. Trio exome sequencing or single exome sequencing followed by segregation analysis were performed in the novel cohort. Functional effects of missense variants were investigated with 3D protein modeling. We included 28 individuals (5 previously published) from 26 families carrying POU3F3 variants; 23 de novo and one inherited from an affected parent. Median age at study inclusion was 7.4 years. All had developmental delay mainly affecting speech, behavioral difficulties, psychiatric comorbidities and dysmorphisms. Additional features included gastrointestinal comorbidities, hearing loss, ophthalmological anomalies, epilepsy, sleep disturbances and joint hypermobility. Autism, hearing and eye comorbidities, dysmorphisms were more common in individuals with truncating variants, whereas epilepsy was only associated with missense variants. In silico structural modeling predicted that all (likely) pathogenic variants destabilize the DNA-binding region of POU3F3. Our study refined the phenotypic and genetic landscape of POU3F3-related disorders, it reports the functional properties of the identified pathogenic variants, and delineates some genotype-phenotype correlations.
AB - POU3F3 variants cause developmental delay, behavioral problems, hypotonia and dysmorphic features. We investigated the phenotypic and genetic landscape, and genotype-phenotype correlations in individuals with POU3F3-related disorders. We recruited unpublished individuals with POU3F3 variants through international collaborations and obtained updated clinical data on previously published individuals. Trio exome sequencing or single exome sequencing followed by segregation analysis were performed in the novel cohort. Functional effects of missense variants were investigated with 3D protein modeling. We included 28 individuals (5 previously published) from 26 families carrying POU3F3 variants; 23 de novo and one inherited from an affected parent. Median age at study inclusion was 7.4 years. All had developmental delay mainly affecting speech, behavioral difficulties, psychiatric comorbidities and dysmorphisms. Additional features included gastrointestinal comorbidities, hearing loss, ophthalmological anomalies, epilepsy, sleep disturbances and joint hypermobility. Autism, hearing and eye comorbidities, dysmorphisms were more common in individuals with truncating variants, whereas epilepsy was only associated with missense variants. In silico structural modeling predicted that all (likely) pathogenic variants destabilize the DNA-binding region of POU3F3. Our study refined the phenotypic and genetic landscape of POU3F3-related disorders, it reports the functional properties of the identified pathogenic variants, and delineates some genotype-phenotype correlations.
KW - Autistic Disorder/genetics
KW - Child
KW - Developmental Disabilities/genetics
KW - Epilepsy/genetics
KW - Humans
KW - Intellectual Disability/genetics
KW - Mutation, Missense/genetics
KW - POU Domain Factors/genetics
KW - Phenotype
U2 - 10.1111/cge.14353
DO - 10.1111/cge.14353
M3 - Article
C2 - 37165752
SN - 0009-9163
VL - 104
SP - 186
EP - 197
JO - Clinical Genetics
JF - Clinical Genetics
IS - 2
ER -